Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 21, 2016; 22(15): 3907-3936
Published online Apr 21, 2016. doi: 10.3748/wjg.v22.i15.3907
Table 4 miRNA observed deregulated in studies enrolling hepatocellular carcinoma patients with hepatitis B virus and hepatitis C virus-related infection in at least three papers
miRNAType of deregulation (number of papers)Type of Sample (number of papers)Ref.
miR-130aDownregulated (4)Tissue (4)Gramantieri L, Cancer Research, 2007 Diaz G, Int J Cancer, 2013 Chung GE, Oncol Rep, 2010 Oksuz Z, Mol Biol Rep, 2015
miR-21Upregulated (3)Tissue (2), serum (1)Ladeiro Y, Hepatology, 2008 Salvi A, Intern J Oncol, 2012 Tomimaru Y, J Hepatol, 2011
miR-224Upregulated (3)Tissue (3)Diaz G, Int J Cancer, 2013 Ladeiro Y, Hepatology, 2008 Murakami Y, Oncogene, 2006
miR-195Downregulated (3)Tissue (3)Gramantieri L, Cancer Research, 2007 Diaz G, Int J Cancer, 2013 Chung GE, Oncol Rep, 2010

  • Citation: Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol 2016; 22(15): 3907-3936
  • URL: https://www.wjgnet.com/1007-9327/full/v22/i15/3907.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v22.i15.3907